0001646343-16-000008.txt : 20160815
0001646343-16-000008.hdr.sgml : 20160815
20160815162407
ACCESSION NUMBER: 0001646343-16-000008
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160630
FILED AS OF DATE: 20160815
DATE AS OF CHANGE: 20160815
EFFECTIVENESS DATE: 20160815
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEXTHERA CAPITAL LP
CENTRAL INDEX KEY: 0001646343
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17280
FILM NUMBER: 161833083
BUSINESS ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 1100
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: (212) 213-7033
MAIL ADDRESS:
STREET 1: 900 THIRD AVENUE
STREET 2: SUITE 1100
CITY: NEW YORK
STATE: NY
ZIP: 10022
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
true
0001646343
XXXXXXXX
06-30-2016
06-30-2016
NEXTHERA CAPITAL LP
900 THIRD AVENUE
SUITE 1100
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-17280
N
Daniel Malek
CEO
6462137033
Daniel Malek
New York
X1
08-15-2016
0
35
115486
false
INFORMATION TABLE
2
NEXTHERA_Q2_13F_FILING.xml
NEXTHERA_Q2_13F_FILING
Abeona Therapeutics Inc
COM
00289Y107
236
100000
SH
SOLE
100000
0
0
Acceleron Pharma Inc
COM
00434H108
3364
99000
SH
SOLE
99000
0
0
Adamas Pharmaceuticals Inc
COM
00548A106
2699
178240
SH
SOLE
178240
0
0
Advaxis Inc
COM NEW
007624208
1011
125000
SH
SOLE
125000
0
0
Aerie Pharmaceuticals Inc
COM
00771V108
1941
110280
SH
SOLE
110280
0
0
Alder Biopharmaceuticals Inc
COM
014339105
974
39000
SH
SOLE
39000
0
0
Amgen Inc
COM
031162100
4565
30000
SH
SOLE
30000
0
0
Aquinox Pharmaceuticals Inc
COM
03842B101
3299
498300
SH
SOLE
498300
0
0
Array BioPharma Inc
COM
04269X105
1855
521000
SH
SOLE
521000
0
0
AVEO Pharmaceuticals Inc
COM
053588109
498
518134
SH
SOLE
518134
0
0
Concert Pharmaceuticals Inc
COM
206022105
2055
183000
SH
SOLE
183000
0
0
Cynapsus Therapeutics Inc
COM PAR NO PAR
23257Y859
4092
244310
SH
SOLE
244310
0
0
Edge Therapeutics Inc
COM
279870109
1373
135836
SH
SOLE
135836
0
0
Eiger BioPharmaceuticals Inc
COM
28249U105
277
14000
SH
SOLE
14000
0
0
FibroGen Inc
COM
31572Q808
2527
154000
SH
SOLE
154000
0
0
Foamix Pharmaceuticals Ltd
SHS
M46135105
922
145250
SH
SOLE
145250
0
0
GlaxoSmithKline PLC
SPONSORED ADR
37733W105
20370
470000
SH
SOLE
470000
0
0
Ignyta Inc
COM
451731103
1274
235000
SH
SOLE
235000
0
0
Immune Design Corp
COM
45252L103
695
85138
SH
SOLE
85138
0
0
ImmunoGen Inc
COM
45253H101
433
140500
SH
SOLE
140500
0
0
Insmed Inc
COM PAR $.01
457669307
1663
168700
SH
SOLE
168700
0
0
Lannett Co Inc
COM
516012101
5472
230000
SH
SOLE
230000
0
0
Minerva Neurosciences Inc
COM
603380106
1092
107000
SH
SOLE
107000
0
0
Mylan NV
SHS EURO
N59465109
6054
140000
SH
SOLE
140000
0
0
Pfizer Inc
COM
717081103
22057
626438
SH
SOLE
626438
0
0
Progenics Pharmaceuticals Inc
COM
743187106
405
96000
SH
SOLE
96000
0
0
SCYNEXIS Inc
COM
811292101
597
275000
SH
SOLE
275000
0
0
Seattle Genetics Inc
COM
812578102
6122
151500
SH
SOLE
151500
0
0
Shire PLC
SPONSORED ADR
82481R106
13622
74000
SH
SOLE
74000
0
0
Tobira Therapeutics Inc
COM
88883P101
942
75000
SH
SOLE
75000
0
0
Trevena Inc
COM
89532E109
945
150000
SH
SOLE
150000
0
0
uniQure NV
SHS
N90064101
688
93400
SH
SOLE
93400
0
0
Verastem Inc
COM
92337C104
437
336000
SH
SOLE
336000
0
0
VistaGen Therapeutics Inc
COM NEW
92840H202
539
138132
SH
SOLE
138132
0
0
Zynerba Pharmaceuticals Inc
COM
98986X109
391
57100
SH
SOLE
57100
0
0